Israel - English - Ministry of Health

teva israel ltd - repaglinide - tablets - repaglinide 0.5 mg - repaglinide - treatment of type ii diabetes.

United States - English - NLM (National Library of Medicine)

novo nordisk - repaglinide (unii: 668z8c33lu) (repaglinide - unii:668z8c33lu) - repaglinide 0.5 mg - prandin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. prandin is contraindicated in patients with: - concomitant use of gemfibrozil [see drug interactions ( 7.1)] - known hypersensitivity to repaglinide or any inactive ingredients risk summary limited available data from case reports and case series with prandin use in pregnant women have not identified a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. there are risks to the mother and fetus associated with poorly controlled diabetes in pregnancy (see clinical considerations) . teratogenicity was not observed in rats and rabbits administered repaglinide during organogenesis at approximately 60 and 1 times the maximum daily clinical dose, based on body surface area. no adverse developmental effects were observed in offspring of rats administered repaglinide during late gestation and lactation at approximately 4 times the maximum daily clinical

Israel - English - Ministry of Health

novo nordisk ltd., israel - repaglinide - tablets - repaglinide 0.5 mg - repaglinide - repaglinide - repaglinide is indicated in adults with type 2 diabetes mellitus whose hyperglycaemia can no longer be controlled satisfactorily by diet, weight reduction and exercise. repaglinide is also indicated in combination with metformin in adults with type 2diabetes mellitus who are not satisfactorily controlled on metformin alone.treatment should be initiated as an adjunct to diet and exercise to lower the blood glucose in relation to meals.

Israel - English - Ministry of Health

novo nordisk ltd., israel - repaglinide - tablets - repaglinide 2 mg - repaglinide - repaglinide - repaglinide is indicated in adults with type 2 diabetes mellitus whose hyperglycaemia can no longer be controlled satisfactorily by diet, weight reduction and exercise. repaglinide is also indicated in combination with metformin in adults with type 2 diabetes mellitus who are not satisfactorily controlled on metformin alone.treatment should be initiated as an adjunct to diet and exercise to lower the blood glucose in relation to meals.

Malta - English - Medicines Authority

sigillata limited (ireland) inniscarra, main street, rathcoole, co. dublin d24 e029 , ireland - repaglinide - tablet - repaglinide 1 mg - drugs used in diabetes

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - repaglinide (unii: 668z8c33lu) (repaglinide - unii:668z8c33lu) - repaglinide 1 mg - prandin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. prandin is contraindicated in patients with:

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - repaglinide (unii: 668z8c33lu) (repaglinide - unii:668z8c33lu) - repaglinide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. limitation of use: repaglinide tablets should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis. repaglinide tablets are contraindicated in patients with: - concomitant use of gemfibrozil [see drug interactions (7)] - known hypersensitivity to repaglinide or any inactive ingredients risk summary limited available data from case reports and case series with repaglinide use in pregnant women have not identified a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. there are risks to the mother and fetus associated with poorly controlled diabetes in pregnancy (see clinical considerations) . teratogenicity was not observed in rats and rabbits administered repaglinide during organogenesis at approximately 60 and 1 times the maximum daily clinical dose, based on body surfac

Israel - English - Ministry of Health

padagis israel agencies ltd, israel - repaglinide - tablets - repaglinide 1 mg - repaglinide - repaglinide is indicated in adults with type 2 diabetes mellitus whose hyperglycaemia can no longer be controlled satisfactorily by diet, weight reduction and exercise. repaglinide is also indicated in combination with metformin in adults with type 2 diabetes mellitus who are not satisfactorily controlled on metformin alone.treatment should be initiated as an adjunct to diet and exercise to lower the blood glucose in relation to meals.

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع خوري - khoury drug store - repaglinide 1 mg - 1 mg

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع خوري - khoury drug store - repaglinide 1 mg - 1 mg